Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 5
- Patient Access
Germany Bans Cannabis Flowers from GKV and Mandates Six-Month Trial for Extracts
Germany has today voted to ban medical cannabis flower from its statutory health insurance scheme, in a controversial move critics say will have an outsized impact on the ‘seriously ill’.
- Clinical Research
Why Medical Companies Win Rescheduling, Whatever Happens to Adult-Use
This week, what is perhaps the most consequential hearing in the history of the US, and indeed the global cannabis industry, is taking place in Arlington, Virginia.
- Medical Cannabis
Cannabis Health Announces Two-City Symposium Series Across Frankfurt and London This Autumn
Cannabis Health, the UK’s leading medical cannabis news and education platform, has announced the launch of two autumn events designed for healthcare professionals, prescribers, and industry operators working at the frontline of medical cannabis practice across Europe.
- Cultivation
‘No Right to GMP Washing’: German State Challenges Cannabis Flower Import Compliance
Authorities from the German state of Hesse have taken aim at the practice of ‘GMP washing’ in its thriving medical cannabis market, an intervention that could have significant implications for the industry at large.
- Cultivation
EU Medical Cannabis Faces Its Most Consequential Regulatory Overhaul
Cultivation is perhaps the most complex, highly regulated, and expensive part of the cannabis supply chain.
- Patient Access
Why a Medical Cannabis Policy Should be Mandatory for Employers
First reported on Cannabis Health Thousands of people in the UK are legally prescribed cannabis-based medicines for chronic health conditions, and employment remains the single biggest reason they seek legal support, new data from Releaf’s legal helpline shows.
- Medical Cannabis
France Breaks Medical Cannabis Deadlock as Reimbursement Decree Filed for Legal Review
France’s incoming generalised medical cannabis framework has edged tantalisingly close to clearing its last remaining hurdle, as the outstanding decree governing the reimbursement of cannabis medicines has been submitted to France’s highest administrative court.
- Medical Cannabis
Who Really Benefits from Britain’s Medical Cannabis System?
Written for Business of Cannabis by Saxon Coop, Founder & CEO of Toke.
- Prescribers & Clinics
Nine of the Ten Top CBPM Prescribers Are Pharmacists, FOI Data Shows
New data acquired by Business of Cannabis has, for the first time, shed light on the professional types behind England’s CBPM prescribing record, raising further questions about assertions that ‘10 doctors prescribe half of the UK’s medical cannabis’.
- Prescribers & Clinics
Curaleaf International Launches CPD-Accredited Education Platform for UK Cannabis Prescribers
Curaleaf International has launched a free CPD-accredited online education platform for UK healthcare professionals to help close the training gap the country’s professional medical community continues to face.
- Medical Cannabis
Curaleaf Laboratories and Herdade das Barrocas (HDB) Announce Strategic Partnership to Reintroduce HDB Products to the UK Medical Cannabis Market
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, are pleased to announce a new manufacturing and supply partnership that will see HDB products reintroduced to healthcare professionals and patients across the United…
- Medical Cannabis
France Sets July Deadline for Medical Cannabis Regulations as Withheld Study Shows Opioid Reductions
France’s health minister has confirmed to Agence France-Presse (AFP) that the delayed regulatory texts needed to push through its incoming generalised medical cannabis market will be published next month (July 2026).
